Do we still need morphologic evaluation in new era of advanced minimal residual disease analyses?

Int J Lab Hematol. 2019 Dec;41(6):e145-e147. doi: 10.1111/ijlh.13045. Epub 2019 May 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Chromosomes, Human, Pair 21 / genetics
  • Chromosomes, Human, Pair 8 / genetics
  • Cytarabine / administration & dosage
  • Humans
  • Leukemia, Myeloid, Acute / blood*
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics
  • Leukemia, Myeloid, Acute / metabolism
  • Male
  • Mitoxantrone / administration & dosage
  • Neoplasm, Residual
  • Translocation, Genetic

Substances

  • Cytarabine
  • Mitoxantrone